TrialRespiratory research2019

Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary disease.

Brian R Leaker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.